vs
Side-by-side financial comparison of ACME UNITED CORP (ACU) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $52.3M, roughly 1.6× ACME UNITED CORP). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 1.9%, a 20.9% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 13.8%). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -2.9%).
Acme United Corporation is a supplier of cutting, measuring and safety products for the school, home, office, hardware and industrial markets. The company was organized as a partnership in 1867 and incorporated in 1873 under the laws of the State of Connecticut. It is publicly traded on the NYSE American with symbol ACU.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
ACU vs FDMT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $52.3M | $85.1M |
| Net Profit | $985.0K | $19.4M |
| Gross Margin | 39.7% | — |
| Operating Margin | 3.3% | 17.3% |
| Net Margin | 1.9% | 22.8% |
| Revenue YoY | 13.8% | 8508900.0% |
| Net Profit YoY | -40.4% | 139.1% |
| EPS (diluted) | $0.24 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $52.3M | — | ||
| Q4 25 | $47.5M | $85.1M | ||
| Q3 25 | $49.1M | $90.0K | ||
| Q2 25 | $54.0M | $15.0K | ||
| Q1 25 | $46.0M | $14.0K | ||
| Q4 24 | $45.9M | $1.0K | ||
| Q3 24 | $48.2M | $3.0K | ||
| Q2 24 | $55.4M | $5.0K |
| Q1 26 | $985.0K | — | ||
| Q4 25 | $1.9M | $19.4M | ||
| Q3 25 | $1.9M | $-56.9M | ||
| Q2 25 | $4.8M | $-54.7M | ||
| Q1 25 | $1.7M | $-48.0M | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $2.2M | $-43.8M | ||
| Q2 24 | $4.5M | $-35.0M |
| Q1 26 | 39.7% | — | ||
| Q4 25 | 38.2% | — | ||
| Q3 25 | 39.1% | — | ||
| Q2 25 | 41.0% | — | ||
| Q1 25 | 39.0% | — | ||
| Q4 24 | 38.7% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 40.8% | — |
| Q1 26 | 3.3% | — | ||
| Q4 25 | 6.1% | 17.3% | ||
| Q3 25 | 6.1% | -67983.3% | ||
| Q2 25 | 11.8% | -396373.3% | ||
| Q1 25 | 5.3% | -383007.1% | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 6.1% | -1704400.0% | ||
| Q2 24 | 11.5% | -849120.0% |
| Q1 26 | 1.9% | — | ||
| Q4 25 | 3.9% | 22.8% | ||
| Q3 25 | 3.9% | -63195.6% | ||
| Q2 25 | 8.8% | -364386.7% | ||
| Q1 25 | 3.6% | -342657.1% | ||
| Q4 24 | 3.7% | — | ||
| Q3 24 | 4.6% | -1461433.3% | ||
| Q2 24 | 8.0% | -699060.0% |
| Q1 26 | $0.24 | — | ||
| Q4 25 | $0.46 | $0.43 | ||
| Q3 25 | $0.46 | $-1.01 | ||
| Q2 25 | $1.16 | $-0.98 | ||
| Q1 25 | $0.41 | $-0.86 | ||
| Q4 24 | $0.43 | — | ||
| Q3 24 | $0.54 | $-0.79 | ||
| Q2 24 | $1.09 | $-0.63 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.2M | $402.7M |
| Total DebtLower is stronger | $33.0M | — |
| Stockholders' EquityBook value | $116.7M | $505.7M |
| Total Assets | $195.2M | $566.7M |
| Debt / EquityLower = less leverage | 0.28× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $4.2M | — | ||
| Q4 25 | $3.6M | $402.7M | ||
| Q3 25 | $5.1M | $305.1M | ||
| Q2 25 | $3.6M | $293.2M | ||
| Q1 25 | $3.4M | $321.4M | ||
| Q4 24 | $6.4M | $424.9M | ||
| Q3 24 | $5.7M | $501.9M | ||
| Q2 24 | $3.8M | $541.9M |
| Q1 26 | $33.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $116.7M | — | ||
| Q4 25 | $117.6M | $505.7M | ||
| Q3 25 | $115.8M | $369.0M | ||
| Q2 25 | $113.7M | $420.9M | ||
| Q1 25 | $108.3M | $469.7M | ||
| Q4 24 | $107.0M | $510.6M | ||
| Q3 24 | $106.3M | $552.9M | ||
| Q2 24 | $104.0M | $588.3M |
| Q1 26 | $195.2M | — | ||
| Q4 25 | $171.0M | $566.7M | ||
| Q3 25 | $173.0M | $424.0M | ||
| Q2 25 | $170.9M | $473.6M | ||
| Q1 25 | $163.0M | $515.7M | ||
| Q4 24 | $162.2M | $560.4M | ||
| Q3 24 | $165.5M | $604.0M | ||
| Q2 24 | $173.5M | $620.1M |
| Q1 26 | 0.28× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $28.6M |
| Free Cash FlowOCF − Capex | — | $28.5M |
| FCF MarginFCF / Revenue | — | 33.5% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $8.2M | $28.6M | ||
| Q3 25 | $7.1M | $-46.5M | ||
| Q2 25 | $6.3M | $-43.4M | ||
| Q1 25 | $-3.3M | $-47.8M | ||
| Q4 24 | $6.4M | $-134.6M | ||
| Q3 24 | $8.9M | $-29.4M | ||
| Q2 24 | $6.9M | $-30.2M |
| Q1 26 | — | — | ||
| Q4 25 | $7.3M | $28.5M | ||
| Q3 25 | $301.0K | $-46.6M | ||
| Q2 25 | $4.7M | $-43.4M | ||
| Q1 25 | $-4.7M | $-48.4M | ||
| Q4 24 | $4.7M | $-138.4M | ||
| Q3 24 | $7.5M | $-31.2M | ||
| Q2 24 | $4.4M | $-30.6M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 33.5% | ||
| Q3 25 | 0.6% | -51765.6% | ||
| Q2 25 | 8.7% | -289620.0% | ||
| Q1 25 | -10.2% | -345635.7% | ||
| Q4 24 | 10.2% | -13837100.0% | ||
| Q3 24 | 15.6% | -1038966.7% | ||
| Q2 24 | 8.0% | -611840.0% |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 0.1% | ||
| Q3 25 | 13.8% | 101.1% | ||
| Q2 25 | 3.0% | 440.0% | ||
| Q1 25 | 2.9% | 4507.1% | ||
| Q4 24 | 3.7% | 378600.0% | ||
| Q3 24 | 2.8% | 59266.7% | ||
| Q2 24 | 4.5% | 6980.0% |
| Q1 26 | — | — | ||
| Q4 25 | 4.34× | 1.47× | ||
| Q3 25 | 3.72× | — | ||
| Q2 25 | 1.33× | — | ||
| Q1 25 | -2.02× | — | ||
| Q4 24 | 3.73× | — | ||
| Q3 24 | 3.99× | — | ||
| Q2 24 | 1.55× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
